Suggestions
Catherine Sohn
Board Director, Chairman of BioEclipse Therapeutics, Former SrVP at GSK, Adjunct Professor at UCSF
Cathy Sohn is a prominent figure in the pharmaceutical industry, known for her roles in various companies and organizations. She currently serves as the Chairman of BioEclipse Therapeutics, a clinical-stage immuno-oncology company focusing on innovative cancer therapies.
Sohn also holds the position of an independent Director on the Board of Directors of several companies including Jazz Pharmaceuticals plc, Rubius Therapeutics, Axcella Health, Maze Therapeutics, and Landec Corp. Her areas of expertise span strategy, strategic product development, business development, commercialization of new medicines and vaccines, and public company governance.
In the academic world, Cathy Sohn engages with students as an Adjunct Professor at UCSF and serves on the Advisory Board of the Gupta Governance Institute at Drexel University. She has a robust background that includes leadership roles at GlaxoSmithKline Consumer Healthcare and SmithKline Beecham Pharmaceuticals.
Among her notable achievements, Dr. Sohn led the global launch of Coreg for congestive heart failure, which grew into a billion-dollar indication. Throughout her career, she has received several accolades and awards, such as being named 'Woman of the Year' by the Healthcare Businesswomen's Association.
Cathy Sohn began her pharmaceutical career in 1982 at SK&F in Medical Affairs after serving as an Assistant Professor at The Philadelphia College of Pharmacy. She holds a Doctor of Pharmacy degree from the University of California, San Francisco, and has pursued additional education, including a Certificate of Professional Development from The Wharton School at the University of Pennsylvania.
Her extensive involvement in the industry is reflected in her roles as a Board Leadership Fellow of the National Association of Corporate Directors (NACD) and as a Certified Licensing Professional Emeritus. Cathy Sohn's rich background encompasses a diverse range of experiences, from academic contributions to corporate governance and business development.
Overall, Cathy Sohn's career highlights her dedication to driving innovation in healthcare and her commitment to shaping the future of medicine through strategic leadership and impactful decision-making.
